- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 265/00 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
Patent holdings for IPC class C07D 265/00
Total number of patents in this class: 56
10-year publication summary
1
|
1
|
0
|
2
|
0
|
3
|
0
|
3
|
4
|
1
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
RespireRx Pharmaceuticals Inc | 11 |
4 |
BASF SE | 19740 |
3 |
Bristol-myers Squibb Company | 5080 |
2 |
Xerox Corporation | 7503 |
2 |
Boehringer Ingelheim International GmbH | 4629 |
2 |
Allergan, Inc. | 2600 |
2 |
University of Miami | 823 |
2 |
Antengene Discovery Limited | 12 |
2 |
Samsung Electronics Co., Ltd. | 131630 |
1 |
F. Hoffmann-La Roche AG | 7958 |
1 |
Merck Sharp & Dohme Corp. | 2247 |
1 |
Janssen Pharmaceutica N.V. | 3839 |
1 |
Abbott Laboratories | 2542 |
1 |
Bayer Cropscience AG | 2241 |
1 |
The Johns Hopkins University | 5377 |
1 |
Alios BioPharma, Inc. | 69 |
1 |
Alkermes Pharma Ireland Limited | 307 |
1 |
AMOREPACIFIC Corporation | 2606 |
1 |
Aurigene Discovery Technologies Limited | 120 |
1 |
Baden-Württemberg Stiftung gGmbH | 64 |
1 |
Other owners | 25 |